Association of messenger RNA level with phenotype in patients with choroideremia: Potential implications for gene therapy dose
JAMA Ophthalmology Feb 20, 2020
Fry LE, Patrício MI, Williams J, et al. - Researchers investigated whether genotype could explain a mild choroideremia phenotype. In this case series study, a mild phenotype was identified in 2 patients with a splice site variant outside the canonical donor sequence (c.940+3delA) vs a cohort of 30 patients with choroideremia. Residual levels of full-length CHM transcript was observed in mildly affected patients, while no CHM transcript was expressed in a control patient with normal disease progression due to a canonical donor splice site variant (c.940+2T>A). The findings thereby suggest an association of residual levels of full-length CHM transcript with milder disease, affording evidence of a relation of genotype with phenotype in choroideremia and implying the transcript level needed to slow degeneration with gene therapy.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries